Literature DB >> 2592856

Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use.

M Massouh1, A Jatoi, E M Gordon, O D Ratnoff.   

Abstract

Inhibition of thrombin by heparin is mediated by at least two plasma proteins, antithrombin III, and heparin cofactor II. The plasma titer of heparin cofactor II was significantly elevated in both pregnant women and users of oral contraceptives.

Entities:  

Keywords:  Biology; Blood Coagulation Effects; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning; Hematological Effects; Hemic System; Hormones; Norethindrone; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Physiology; Pituitary Hormones; Pregnancy; Prolactin; Reproduction; Research Methodology; Studies

Mesh:

Substances:

Year:  1989        PMID: 2592856

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Heparin cofactor II inhibits arterial thrombosis after endothelial injury.

Authors:  Li He; Cristina P Vicente; Randal J Westrick; Daniel T Eitzman; Douglas M Tollefsen
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.

Authors:  M Andrew; L Mitchell; L Berry; B Paes; M Delorme; F Ofosu; R Burrows; B Khambalia
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.

Authors:  Tusar K Giri; Douglas M Tollefsen
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.